Liu F, Ma R, Wang Y, Zhang L. The clinical importance of Campylobacter concisus and other human hosted Campylobacter Species. Front Cell Infect Microbiol. 2018;8:243.
Article PubMed PubMed Central Google Scholar
Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J, et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by campylobacter concisus and other non– Campylobacter jejuni Campylobacter species. J Infect Dis. 2010;202(12):1855–65.
Article CAS PubMed Google Scholar
Nielsen HL, Ejlertsen T, Engberg J, Nielsen H. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect. 2013;19:445–50.
Article CAS PubMed Google Scholar
Nielsen HL, Engberg J, Ejlertsen T, Bücker R, Nielsen H. Short-term and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect. 2012;18(11):E459.
Article CAS PubMed Google Scholar
Aagaard MEY, Kirk KF, Nielsen HL, Tarpgaard IH, Hansen JB, Nielsen H. Campylobacter concisus is prevalent in the gastrointestinal tract of patients with microscopic colitis. Scand J Gastroenterol. 2020;55:924–30.
Nielsen HL, Dalager-Pedersen M, Nielsen H. High risk of microscopic colitis after Campylobacter concisus infection: population-based cohort study. Gut. 2020;69:1952–8.
Kirk KF, Nielsen HL, Thorlacius-Ussing O, Nielsen H. Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease. Gut Pathog. 2016;8:27.
Article PubMed PubMed Central Google Scholar
Nielsen HL, Dalager-Pedersen M, Nielsen H. Risk of inflammatory bowel disease after Campylobacter jejuni and Campylobacter concisus infection: a population-based cohort study. Scand J Gastroenterol. 2019;54:265–72.
Costa D, Iraola G. Pathogenomics of emerging Campylobacter species. Clin Microbiol Rev. 2019;32:1–24.
Kirk KF, Meric G, Nielsen HL, Pascoe B, Sheppard SK, Thorlacius-Ussing O, et al. Molecular epidemiology and comparative genomics of Campylobacter concisus strains from saliva, faeces and gut mucosal biopsies in inflammatory bowel disease. Sci Rep. 2018;8:1902.
Article PubMed PubMed Central Google Scholar
Istivan TS, Coloe PJ, Fry BN, Ward P, Smith SC. Characterization of a haemolytic phospholipase A2 activity in clinical isolates of Campylobacter concisus. J Med Microbiol. 2004;53(6):483–93.
Article CAS PubMed Google Scholar
Ismail Y, Lee H, Riordan SM, Grimm MC, Zhang L. The effects of oral and enteric campylobacter concisus strains on expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 cells. PLoS ONE. 2013;8:e56888.
Article CAS PubMed PubMed Central Google Scholar
Daig R, Andus T, Aschenbrenner E, Falk W, Schölmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut. 1996;38:216–22.
Article CAS PubMed PubMed Central Google Scholar
Cotton JA, Platnich JM, Muruve DA, Jijon HB, Buret AG, Beck PL. Interleukin-8 in gastrointestinal inflammation and malignancy: induction and clinical consequences. Int J Interferon Cytokine Mediat Res. 2016;8:13–34.
Kalischuk LD, Inglis GD. Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-diarrheic humans. BMC Microbiol. 2011;11:53.
Article CAS PubMed PubMed Central Google Scholar
Mahendran V, Liu F, Riordan SM, Grimm MC, Tanaka MM, Zhang L. Examination of the effects of Campylobacter concisus zonula occludens toxin on intestinal epithelial cells and macrophages. Gut Pathog. 2016;8:18.
Article PubMed PubMed Central Google Scholar
Deshpande NP, Wilkins MR, Castaño-Rodríguez N, Bainbridge E, Sodhi N, Riordan SM, et al. Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells. Sci Rep. 2016;6:34288.
Article CAS PubMed PubMed Central Google Scholar
Martínez-Maqueda D, Miralles B, Recio I, et al. HT29 cell line. In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, et al., editors. The impact of food bioactives on health: in vitro and ex vivo models. Springer International Publishing; 2015. p. 113–24.
McFarland J. No the nephelometer: an instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines. J Am Med Assoc. 1907;49:1176–8.
Davies E, Ebbesen M, Johansson C, Kaden R, Rautelin H. Genomic and phenotypic characterisation of Campylobacter jejuni isolates from a waterborne outbreak. Front Cell Infect Microbiol. 2020;10:594856.
Article CAS PubMed PubMed Central Google Scholar
Peters S, Pascoe B, Wu Z, Bayliss SC, Zeng X, Edwinson A, et al. Campylobacter jejuni genotypes are associated with post-infection irritable bowel syndrome in humans. Commun Biol. 2021;4(1):1015.
Article CAS PubMed PubMed Central Google Scholar
Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn’s disease. Clin Exp Immunol. 1994;96:432–6.
Article CAS PubMed PubMed Central Google Scholar
Sorensen NB, Nielsen HL, Varming K, Nielsen H. Neutrophil activation by Campylobacter concisus. Gut Pathog. 2013;5:17.
Article PubMed PubMed Central Google Scholar
Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Munch A. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol. 2019;4:305–14.
Kumawat AK, Strid H, Tysk C, Bohr J, Hornquist EH. Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol. 2013;55:355–64.
Article CAS PubMed Google Scholar
Tagkalidis PP, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol. 2007;60:382–7.
Article CAS PubMed Google Scholar
Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, et al. Immunological differences between lymphocytic and collagenous colitis. J Crohns Colitis. 2016;10:1055–66.
Gunaltay S, Kumawat AK, Nyhlin N, Bohr J, Tysk C, Hultgren O, et al. Enhanced levels of chemokines and their receptors in the colon of microscopic colitis patients indicate mixed immune cell recruitment. Mediators Inflamm. 2015;2015:132458.
Article PubMed PubMed Central Google Scholar
Dey I, Beck PL, Chadee K. Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4. PLoS ONE. 2013;8:e61891.
留言 (0)